Universität zu Köln

Li, Jeany Q., Kellner, Ulrich, Lorenz, Birgit, Stahl, Andreas and Krohne, Tim U. (2021). Screening for retinopathy of prematurity-the most important changes in the new German guidelines 2020. Ophthalmologe, 118 (12). S. 1240 - 1245. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0423

Full text not available from this repository.

Abstract

Background Due to improvements in neonatal care of premature infants and the development of novel treatment options for retinopathy of prematurity (ROP), the requirements for screening for ROP have changed since publication of the last version of the German ROP screening guideline in 2008. Based on results of recent studies, the guideline has been extensively revised in 2020 and published in an updated version. Objective This article summarizes the most important changes in the new guideline. Results The age limit for screening inclusion was lowered to a gestational age of below 31 weeks for infants without additional risk factors. The minimum duration of oxygen supplementation necessitating screening inclusion in preterm infants was increased to more than 5 days. Treatment for ROP in zone II can now be given at any stage 3 with plus disease, regardless of the number of clock hours affected. Criteria for the frequency and duration have been defined for follow-up examinations after anti-vascular endothelial growth factor (VEGF) treatment. The binding document for these and other new recommendations is the guideline itself. Conclusion The guideline recommendations enable a reliable identification of infants at risk for ROP for screening inclusion and a timely detection of advanced disease stages for treatment initiation, thus preventing blindness from ROP.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Li, Jeany Q. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kellner, Ulrich UNSPECIFIED UNSPECIFIED UNSPECIFIED Lorenz, Birgit UNSPECIFIED UNSPECIFIED UNSPECIFIED Stahl, Andreas UNSPECIFIED UNSPECIFIED UNSPECIFIED Krohne, Tim U. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-589966
DOI:	10.1007/s00347-021-01393-6
Journal or Publication Title:	Ophthalmologe
Volume:	118
Number:	12
Page Range:	S. 1240 - 1245
Date:	2021
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1433-0423
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language INTRAVITREAL BEVACIZUMAB; REACTIVATION; RANIBIZUMAB; SWEDROP Multiple languages Ophthalmology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/58996